Search
for
Sort by
Research 91–120 of 1000+
- 5α‐reductase inhibitors: Evaluation of their potential confounding effect on GC‐C‐IRMS doping analysis
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- Aqueous extract of Asiasari radix inhibits formalin-induced hyperalgesia via NMDA receptors
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Anti-androgenic curcumin analogues as steroid 5-alpha reductase inhibitors
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- PNU 157706, a novel dual type I and II5α-reductase inhibitor
- 713 Fisetin promotes differentiation, inhibits proliferative and inflammatory responses in cultured human cells and alleviates psoriasiform dermatitis in mice
- Synthesis and in vitro study of 17β-[N-ureylene-N,N′-disubstituted]-4-methyl-4-aza-5α-androstan-3-ones as selective inhibitors of type I 5α-reductase
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Estrogenic Potential of 2-Alkyl-4-(thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- SAT-288 Successful Virilization of a PAIS Patient with a Missense Mutation In The Ligand-binding Domain Of The Androgen Receptor with Combined High-dose Testosterone and Aromatase Inhibitor
- Pharmacology of antiandrogens
- Re: Associations Between Variants in the Cyclooxygenase 2 Enzyme Gene (PTGS2) and Development of Benign Prostate Enlargement
- Emerging medication for the treatment of male hypogonadism
- Aromatase-independent testosterone conversion into estrogenic steroids is inhibited by a 5α-reductase inhibitor
- Clinical applications of antiandrogens
- Cutaneous toxicities of new treatments for melanoma
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Field Cancerization: From Molecular Basis to Selective Field-Directed Management of Actinic Keratosis
- Novel 5α-Reductase Inhibitors: Synthesis, Structure−Activity Studies, and Pharmacokinetic Profile of Phenoxybenzoylphenyl Acetic Acids
- Reduced estradiol synthesis by letrozole, an aromatase inhibitor, is protective against development of pentylenetetrazole-induced kindling in mice
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors